Table of Contents
ISRN Urology
Volume 2012, Article ID 272697, 8 pages
http://dx.doi.org/10.5402/2012/272697
Research Article

AKT/mTOR as Novel Targets of Polyphenol Piceatannol Possibly Contributing to Inhibition of Proliferation of Cultured Prostate Cancer Cells

1Department of Biochemistry & Molecular Biology, New York Medical College, Valhalla, New York 10595, USA
2Genome and Systems Biology Degree Program, National Taiwan University, Taipei 10617, Taiwan
3Signal Transduction Laboratory, Ordway Research Institute, Albany, NY 12208, USA

Received 28 November 2011; Accepted 2 January 2012

Academic Editors: P.-L. Chang and T. Nelius

Copyright © 2012 Tze-Chen Hsieh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Cantos, J. C. Espin, M. J. Fernandez, J. Oliva, and F. A. Tomas-Barberan, “Postharvest UV-C-irradiated grapes as a potential source for producing stilbene-enriched red wines,” Journal of Agricultural and Food Chemistry, vol. 51, no. 5, pp. 1208–1214, 2003. View at Publisher · View at Google Scholar
  2. A. M. Rimando, W. Kalt, J. B. Magee, J. Dewey, and J. R. Ballington, “Resveratrol, pterostilbene, and piceatannol in vaccinium berries,” Journal of Agricultural and Food Chemistry, vol. 52, no. 15, pp. 4713–4719, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. K. L. Ku, P. S. Chang, Y. C. Cheng, and C. Y. Lien, “Production of stilbenoids from the callus of arachis hypogaea: a novel source of the anticancer compound piceatannol,” Journal of Agricultural and Food Chemistry, vol. 53, no. 10, pp. 3877–3881, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. S. Son, S. A. Park, H. K. Na, D. M. Jue, S. Kim, and Y. J. Surh, “Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-{κ}B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK {β} as a potential target,” Carcinogenesis, vol. 31, no. 8, pp. 1442–1449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. R. Ferrigni, J. L. McLaughlin, R. G. Powell, and C. R. Smith Jr., “Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae,” Journal of Natural Products, vol. 47, no. 2, pp. 347–352, 1984. View at Google Scholar · View at Scopus
  6. T. Yokozawa and Y. J. Kim, “Piceatannol inhibits melanogenesis by its antioxidative actions,” Biological and Pharmaceutical Bulletin, vol. 30, no. 11, pp. 2007–2011, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Rossi, F. Caruso, C. Opazo, and J. Salciccioli, “Crystal and molecular structure of piceatannol; scavenging features of resveratrol and piceatannol on hydroxyl and peroxyl radicals and docking with transthyretin,” Journal of Agricultural and Food Chemistry, vol. 56, no. 22, pp. 10557–10566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Djoko, R. Y. Chiou, J. J. Shee, and Y. W. Liu, “Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages,” Journal of Agricultural and Food Chemistry, vol. 55, no. 6, pp. 2376–2383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Liu, D. H. Kim, J. M. Park, H. K. Na, and Y. J. Surh, “Piceatannol inhibits phorbol ester-induced NF-κ B activation and COX-2 expression in cultured human mammary epithelial cells,” Nutrition and Cancer, vol. 61, no. 6, pp. 855–863, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Wieder, A. Prokop, B. Bagci et al., “Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts,” Leukemia, vol. 15, no. 11, pp. 1735–1742, 2001. View at Google Scholar · View at Scopus
  11. F. Wolter, A. Clausnitzer, B. Akoglu, and J. Stein, “Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines,” Journal of Nutrition, vol. 132, no. 2, pp. 298–302, 2002. View at Google Scholar · View at Scopus
  12. M. Larrosa, F. A. Tomás-Barberán, and J. C. Espín, “The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells,” European Journal of Nutrition, vol. 43, no. 5, pp. 275–284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Ashikawa, S. Majumdar, S. Banerjee, A. C. Bharti, S. Shishodia, and B. B. Aggarwal, “Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of I κBalpha kinase and p65 phosphorylation,” Journal of Immunology, vol. 169, no. 11, pp. 6490–6497, 2002. View at Google Scholar · View at Scopus
  14. J. Youn, J. S. Lee, H. K. Na, J. K. Kundu, and Y. J. Surh, “Resveratrol and piceatannol inhibit iNOS expression and NF-κB activation in dextran sulfate sodium-induced mouse colitis,” Nutrition and Cancer, vol. 61, no. 6, pp. 847–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kimura, K. Baba, and H. Okuda, “Inhibitory effects of active substances isolated from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice—part 2,” Anticancer Research, vol. 20, no. 5, pp. 2923–2930, 2000. View at Google Scholar · View at Scopus
  16. J. M. Oliver, D. L. Burg, B. S. Wilson, J. L. McLaughlin, and R. L. Geahlen, “Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol,” Journal of Biological Chemistry, vol. 269, no. 47, pp. 29697–29703, 1994. View at Google Scholar · View at Scopus
  17. H. E. Speich, S. Grgurevich, T. J. Kueter, A. D. Earhart, S. M. Slack, and L. K. Jennings, “Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress,” American Journal of Physiology, vol. 295, no. 4, pp. C1045–C1054, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Takada and B. B. Aggarwal, “TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-κB activation, and apoptosis,” Journal of Immunology, vol. 173, no. 2, pp. 1066–1077, 2004. View at Google Scholar · View at Scopus
  19. R. L. Geahlen and J. L. McLaughlin, “Piceatannol (3,4,3,5-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor,” Biochemical and Biophysical Research Communications, vol. 165, no. 1, pp. 241–245, 1989. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. Law, L. Nannizzi-Alaimo, K. Ministri et al., “Genetic and pharmacological analyses of Syk function in alphaIIbβ3 signaling in platelets,” Blood, vol. 93, no. 8, pp. 2645–2652, 1999. View at Google Scholar · View at Scopus
  21. B. H. Wang, Z. X. Lu, and G. M. Polya, “Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol,” Planta Medica, vol. 64, no. 3, pp. 195–199, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Zheng and V. D. Ramirez, “Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex,” Biochemical and Biophysical Research Communications, vol. 261, no. 2, pp. 499–503, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Gledhill, M. G. Montgomery, A. G. Leslie, and J. E. Walker, “Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13632–13637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. B. E. Barton, J. G. Karras, T. F. Murphy, A. Barton, and H. F. Huang, “Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines,” Molecular Cancer Therapeutics, vol. 3, no. 1, pp. 11–20, 2004. View at Google Scholar · View at Scopus
  25. E. J. Kim, H. Park, S. Y. Park, J. G. Jun, and J. H. Park, “The grape component piceatannol induces apoptosis in DU145 human prostate cancer cells via the activation of extrinsic and intrinsic pathways,” Journal of Medicinal Food, vol. 12, no. 5, pp. 943–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. M. Lee, D. Y. Lim, H. J. Cho et al., “Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity,” Cancer Letters, vol. 285, no. 2, pp. 166–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell, “The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 7, pp. 1330–1340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Ciuffreda, C. D. Sanza, U. C. Incani, and M. Milella, “The mTOR pathway: a new target in cancer therapy,” Current Cancer Drug Targets, vol. 10, no. 5, pp. 484–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. T. C. Hsieh and J. M. Wu, “Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines,” Experimental Cell Research, vol. 249, no. 1, pp. 109–115, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Elangovan, T. C. Hsieh, and J. M. Wu, “Growth inhibition of human MDA-MB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product,” Anticancer Research, vol. 28, no. 5, pp. 2641–2647, 2008. View at Google Scholar · View at Scopus
  31. A. M. DiPietrantonio, T. C. Hsieh, S. C. Olson, and M. W. U. Joseph, “Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR),” International Journal of Cancer, vol. 78, no. 1, pp. 53–61, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Darzynkiewicz, E. Bedner, and P. Smolewski, “Flow cytometry in analysis of cell cycle and apoptosis,” Seminars in Hematology, vol. 38, no. 2, pp. 179–193, 2001. View at Google Scholar · View at Scopus
  33. H. Otera, S. Ohsakaya, Z. Nagaura, N. Ishihara, and K. Mihara, “Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space,” EMBO Journal, vol. 24, no. 7, pp. 1375–1386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. E. P. Rogakou, D. R. Pilch, A. H. Orr, V. S. Ivanova, and W. M. Bonner, “DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139,” Journal of Biological Chemistry, vol. 273, no. 10, pp. 5858–5868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. J. P. Banath and P. L. Olive, “Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks,” Cancer Research, vol. 63, no. 15, pp. 4347–4350, 2003. View at Google Scholar · View at Scopus
  36. T. Tanaka, H. D. Halicka, X. Huang, F. Traganos, and Z. Darzynkiewicz, “Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants,” Cell Cycle, vol. 5, no. 17, pp. 1940–1945, 2006. View at Google Scholar · View at Scopus
  37. L. Furic, L. Rong, O. Larsson et al., “EIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14134–14139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Yu, C. Scott, W. W. Jia et al., “Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter,” Cancer Gene Therapy, vol. 13, no. 1, pp. 32–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Pullen and G. Thomas, “The modular phosphorylation and activation of p70(s6k),” FEBS Letters, vol. 410, no. 1, pp. 78–82, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Dufner and G. Thomas, “Ribosomal S6 kinase signaling and the control of translation,” Experimental Cell Research, vol. 253, no. 1, pp. 100–109, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. J. R. Graff, B. W. Konicek, A. M. McNulty et al., “Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27(Kip1) expression,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24500–24505, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. C. W. Kinkade, M. Castillo-Martin, A. Puzio-Kuter et al., “Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model,” Journal of Clinical Investigation, vol. 118, no. 9, pp. 3051–3064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Fu, S. Wey, M. Wang et al., “Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19444–19449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. B. D. Manning, A. R. Tee, M. N. Logsdon, J. Blenis, and L. C. Cantley, “Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway,” Molecular Cell, vol. 10, no. 1, pp. 151–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Inoki, Y. Li, T. Zhu, J. Wu, and K. L. Guan, “TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling,” Nature Cell Biology, vol. 4, no. 9, pp. 648–657, 2002. View at Publisher · View at Google Scholar